Australia’s active vaccine safety system

AusVaxSafety commenced routine safety monitoring of 2024 seasonal influenza vaccines used in Australia across all ages in March 2024.

The influenza vaccines in use in Australia in 2024 are:

Standard influenza vaccines

  • Afluria® Quad (individuals aged 5 years and older)
  • Fluarix Tetra® (individuals aged 6 months and older)
  • Flucelvax® Quad (individuals aged 6 months and older)
  • FluQuadri® (individuals aged 6 months and older)
  • Influvac® Tetra (individuals aged 6 months and older)
  • Vaxigrip Tetra® (individuals aged 6 months and older).

Adjuvanted or high-dose vaccines

  • Fluad® Quad (individuals aged 65 years and over)
  • Fluzone® High-Dose Quad (individuals aged 60 years and over).

Surveillance data are gathered via AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination.

Latest influenza vaccine safety data

Click on the tiles below to view 2024 AusVaxSafety influenza vaccine safety data for specific age and population groups. Note: Additional age and population groups will be added below once enough data are collected for meaningful analysis.